logo-loader
viewRio Tinto plc

Rio Tinto to fund uranium mine clean-up

The giant miner vowed to subscribe to US$221mln rights shares of subsidiary Energy Resources of Australia and will fully underwrite its US$326mln equity fundraising if no other entity does so

Rio Tinto plc - Rio Tinto to fund uranium mine clean-up
The mine is located within the huge Kakadu National Park in Australia

Rio Tinto plc’s (LON:RIO) shares ticked higher after the giant miner vowed to subscribe to US$221mln rights shares of subsidiary Energy Resources of Australia (ERA) to clean up a uranium mine.

The FTSE 100-listed firm also agreed to fully underwrite ERA’s US$326mln equity fundraising if no other entity does so.

READ: Rio Tinto to review future of world’s purest aluminium smelter amid “challenging” market

ERA, in which Rio owns a 68% stake, has been looking to raise funds for years in order to close and rehabilitate the uranium mine in the Ranger Project Area, in Australia's Northern Territory.

Last February, ERA completed a feasibility study which showed a “material” rise in costs to clean up the mine, scheduled to halt all operations by 2021 and finalise rehab works by 2026.

The project, located within the huge Kakadu National Park, has been the stage of over 200 environmental incidents between 1979 and 2003, according to Reuters reports.

“We have committed to supporting this offer with the objective of ensuring ERA is in a position to rehabilitate Ranger to a standard that will establish an environment similar to the adjacent Kakadu National Park,” said Bold Baatar, Rio Tinto’s group executive for energy & minerals.

Shares in Rio Tinto were up 2% in London to 4,178p on Friday morning.

Quick facts: Rio Tinto plc

Price: 4256.5 GBX

LSE:RIO
Market: LSE
Market Cap: £71.69 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Summit Therapeutics' Glyn Edwards talks US$50mln backing and ridinilazole...

Summit Therapeutics PLC's (LON:SUMM, NASDAQ:SMMT) CEO Glyn Edwards sat down with Proactive London's Andrew Scott following the news of a US$50mln funding deal with biotech billionaire Bob Duggan. The investment will help get the company’s next-generation antibiotic through phase III clinical...

6 hours, 2 minutes ago

RNS

Transaction in Own Shares

4 hours, 29 minutes ago

Transaction in Own Shares

3 days, 4 hours ago

Transaction in Own Shares

4 days, 4 hours ago

Transaction in Own Shares

5 days, 4 hours ago

Director/PDMR Shareholding

5 days, 5 hours ago

Director/PDMR Shareholding

5 days, 5 hours ago

Transaction in Own Shares

6 days, 3 hours ago

2 min read